Midodrine 10 mg Tablet
Description
RODRINE-10
Midodrine 10 mg Tablets
Division: DIABGLYM
Composition
Each tablet contains:
Midodrine Hydrochloride IP — 10 mg
Excipients — q.s.
Colour: Approved colour used
Dosage form: Oral tablet
Product Description
RODRINE-10 contains Midodrine Hydrochloride 10 mg, a selective alpha-1 adrenergic agonist formulated for the effective management of symptomatic orthostatic hypotension, autonomic dysfunction, and chronic low blood pressure. Midodrine increases peripheral vascular tone and improves standing blood pressure, helping reduce symptoms such as dizziness, lightheadedness, fainting, weakness, blurred vision, and fatigue associated with orthostatic hypotension.
Midodrine is widely used in cardiology, neurology, nephrology, and autonomic medicine for patients with autonomic failure, diabetic autonomic neuropathy, neurogenic orthostatic hypotension, and chronic symptomatic hypotension. It improves upright blood pressure and enhances functional capacity and quality of life in patients with disabling hypotensive symptoms.
RODRINE-10 is particularly beneficial for patients with autonomic dysfunction, diabetic neuropathy with orthostatic hypotension, Parkinson’s disease-related hypotension, chronic low blood pressure, and postural blood pressure instability requiring pharmacological support.
Technical Knowledge of Midodrine
Midodrine is a prodrug that is rapidly converted to its active metabolite, desglymidodrine, which selectively stimulates peripheral alpha-1 adrenergic receptors. Activation of these receptors produces arterial and venous vasoconstriction, leading to increased peripheral vascular resistance, improved venous return, and elevation of systemic blood pressure.
Unlike many sympathomimetic agents, Midodrine has minimal direct central nervous system activity because its active metabolite crosses the blood-brain barrier poorly. Its therapeutic effect is primarily peripheral, making it effective for improving standing blood pressure without significant central stimulation.
Mechanism of Action
Midodrine is converted to desglymidodrine, selectively stimulates peripheral alpha-1 adrenergic receptors, increases arterial and venous vascular tone, raises peripheral vascular resistance, improves venous return, and elevates standing blood pressure.
Key Benefits
Effective treatment of symptomatic orthostatic hypotension
Improves standing blood pressure
Reduces dizziness and lightheadedness
Helps prevent syncope and near-syncope episodes
Improves functional capacity and daily activity
Supports patients with autonomic dysfunction
Provides targeted peripheral vasoconstrictive action
Suitable for long-term management under medical supervision
Clinical Applications
RODRINE-10 is commonly prescribed for symptomatic orthostatic hypotension, neurogenic orthostatic hypotension, autonomic dysfunction, diabetic autonomic neuropathy, Parkinson’s disease-related hypotension, chronic symptomatic hypotension, postural blood pressure instability, and autonomic failure syndromes.
Facts About Midodrine
Midodrine is one of the most widely used oral vasopressor agents for symptomatic orthostatic hypotension and has established clinical efficacy in improving upright blood pressure and reducing orthostatic symptoms. Because it can increase supine blood pressure, blood pressure monitoring and appropriate dosing schedules are important during therapy.
Key Facts
Selective alpha-1 adrenergic agonist
Midodrine 10 mg for orthostatic hypotension management
Improves standing blood pressure and circulation
Reduces dizziness, weakness, and syncope
Widely used in autonomic and cardiovascular disorders
Quality-assured pharmaceutical formulation
PCD Pharma Franchise Opportunity
RODRINE-10 is an excellent product for PCD Pharma Franchise, Cardiology Franchise, Neurology Franchise, and Specialty Pharma Franchise across India. The increasing recognition of autonomic disorders, diabetic neuropathy, chronic hypotension, and elderly cardiovascular care creates strong prescription demand and long-term market potential for this formulation.
Why Choose RODRINE-10 for PCD Pharma Franchise?
High prescription potential
Strong physician, cardiologist, and neurologist acceptance
Attractive monopoly franchise opportunity
Competitive pricing
Promotional support available
Visual aids and marketing inputs
Consistent product quality
Excellent repeat business potential
Third Party Manufacturing
Chemsroot Pharmaceutical offers Third Party Manufacturing of Midodrine 10 mg Tablets with complete manufacturing support for pharmaceutical companies, marketers, exporters, and franchise businesses.
Our Third Party Manufacturing Services Include
Private label manufacturing
Contract manufacturing
Custom brand manufacturing
Loan license manufacturing
DCGI-compliant production
GMP-certified manufacturing
Batch manufacturing documentation
Product registration support
Customized packaging and artwork
Monopoly franchise packaging
Bulk manufacturing capability
Manufacturing Features
Pharmaceutical-grade raw materials
IP/BP/USP quality standards
In-process quality control
Finished product testing
Stability-oriented formulation
Moisture-controlled tablet manufacturing
Blister and Alu-Alu packaging options
RODRINE-10 from DIABGLYM combines effective blood pressure support, targeted peripheral vasoconstriction, comprehensive autonomic care, and high-quality pharmaceutical manufacturing, making it an ideal product for physicians, cardiologists, neurologists, nephrologists, PCD Pharma Franchise partners, and Third Party Manufacturing clients seeking a reliable and evidence-based Midodrine formulation.
